Subclinical Afib Caught on Cardiac Devices Might Be Better Left Alone

(MedPage Today) -- AMSTERDAM -- Edoxaban (Savaysa) didn't improve outcomes for high-risk patients with subclinical atrial fibrillation (Afib)-like episodes detected by implanted cardiac devices, the NOAH-AFNET 6 trial showed. The direct oral...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news